Target intelligence / Profile preview

Ribosomal protein L22 pseudogene 24 (RPL22P24)

Target
RPL22P24
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L22 pseudogene 24 (RPL22P24) is a processed pseudogene in the human genome, sharing sequence similarity with the gene encoding ribosomal protein L22 but not producing a functional protein product. It belongs to the group of ribosomal pseudogenes distributed throughout the genome, reflecting gene duplication and retrotransposition events. Unlike the functional RPL22 gene, which is part of the ribosome's 60S large subunit and participates in protein synthesis, RPL22P24 does not contribute to ribosome structure or function, has no recognized biological or pathological role, and is not targeted by drugs or used clinically[4][7]. In summary: RPL22P24 is a non-coding pseudogene, not a protein, receptor, enzyme, or drug target, and has no current therapeutic, biological, or clinical significance. It should not be considered or annotated as a druggable or marker target[4][7].

02

Mechanism of action

None (no known mechanism of action; not a target for drugs)

03

Biological functions

Other (No known functional protein product; does not participate in standard biological activities)
04

Disease associations

Other (No established disease association; not a direct disease gene or target)

Beyond the preview

Go deeper on Ribosomal protein L22 pseudogene 24 (RPL22P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L22 pseudogene 24 (RPL22P24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call